Prognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Oxford University Press
Access Rights
info:eu-repo/semantics/embargoedAccess
DOI
Abstract
Description
Conference Conference: 44th Congress of the European-Society-for-Medical-Oncology (ESMO) Location: Barcelona, SPAIN Date: SEP 27-OCT 01, 2019 Sponsor(s):European Soc Med Oncol; Japanese Soc Med Oncol
Keywords
Journal or Series
44th Congress of the European-Society-for-Medical-Oncology (ESMO)
WoS Q Value
Scopus Q Value
Volume
30
Issue
Supplement: 5
Citation
Üskent, N., Ayla, Ş., Mandel, N. M., Özkan, M., Teomete, M., Baloğlu, H. ... Yazar, A. (2019). Prognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy. 44th Congress of the European-Society-for-Medical-Oncology (ESMO). Barcelona, Spain, September 27-October 01, 2019.
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
info:eu-repo/semantics/embargoedAccess
